The recombinant Clostridium botulinum ATP synthase subunit alpha (atpA), partial, is a truncated protein derived from the α-subunit of the V-type ATP synthase (ATPase) complex. This enzyme is critical for proton transport and ATP synthesis in C. botulinum, a Gram-positive bacterium known for producing botulinum neurotoxin (BoNT). The recombinant version is engineered for research purposes, typically expressed in heterologous systems such as E. coli, yeast, or mammalian cells, and is characterized by partial sequence coverage (e.g., amino acids 1–504) .
The atpA protein (Uniprot ID: A7G9Q7) is a partial fragment of the full-length α-subunit. Key structural features include:
N-terminal sequence: MNIKPEEITS IIRQQIENFN TNIETIDSGT IIQIGDGIAR VYGLEDCMEG...
Functional domains: The α-subunit typically binds ATP and participates in proton translocation and ATP synthesis within the V-type ATPase complex .
The V-type ATP synthase in C. botulinum is essential for maintaining cellular pH and ATP levels, particularly under anaerobic conditions. While the full α-subunit is involved in ATP hydrolysis or synthesis, the recombinant partial atpA is primarily used as a research tool to study:
Enzyme kinetics: Binding affinity for ATP or ADP.
Protein-protein interactions: With other subunits (e.g., β-subunit) of the ATPase complex .
The partial atpA is produced via recombinant DNA technology in various hosts:
| Host System | Advantages | Applications |
|---|---|---|
| E. coli | High yield, cost-effective | Structural studies, antibody production |
| Yeast | Proper post-translational modifications | Functional assays (e.g., ATP binding) |
| Baculovirus | Native folding in insect cells | Tertiary structure analysis |
| Mammalian cells | Human-like protein processing | Therapeutic protein development (N/A) |
Note: The protein is not used therapeutically, as it is a research-grade reagent .
KEGG: cbh:CLC_0202
ATP synthase subunit alpha constitutes a critical component of the F1 portion of the F1F0-ATP synthase complex in C. botulinum. This enzyme catalyzes ATP synthesis through oxidative phosphorylation, converting ADP and inorganic phosphate to ATP using the energy from proton gradients. The alpha subunit contains nucleotide binding domains and works cooperatively with the beta subunit to facilitate the catalytic mechanism of ATP synthesis.
In C. botulinum, ATP synthase represents a crucial element of energy metabolism, particularly considering that this organism can grow in both anaerobic and relatively aerobic conditions. The protein contains several conserved structural domains including nucleotide-binding regions that are essential for its catalytic function .
The expression pattern of atpA in C. botulinum likely varies with growth phase and environmental conditions. Based on regulatory patterns observed in the botulinum toxin gene cluster, atpA expression may be regulated during the transition between exponential and stationary growth phases.
Evidence suggests that in C. botulinum, regulatory systems including two-component systems (TCSs) control gene expression in response to environmental signals throughout growth phases. Similar to toxin gene expression, which peaks during the transition from exponential to stationary phase, atpA expression may follow coordinated regulatory patterns to meet changing energy demands .
Several complementary techniques provide robust analysis of atpA expression:
Quantitative real-time PCR (qRT-PCR): This technique allows precise measurement of transcript levels normalized to reference genes like rpoB, as demonstrated in toxin gene expression studies in C. botulinum .
Northern blotting: Useful for determining transcript size and confirming operon structure.
Reporter gene fusions: Constructing fusions between the atpA promoter and reporter genes enables visualization of expression patterns.
RNA-seq: Provides comprehensive transcriptome analysis to identify co-regulated genes and regulatory networks involving atpA.
Antisense RNA approach: The mRNA antisense methodology used for studying toxin regulatory genes can be adapted to investigate atpA regulation .
The relationship between ATP synthase function and botulinum neurotoxin (BoNT) production involves several potential mechanisms:
Energy provision: Toxin production is energetically demanding, requiring sufficient ATP supply generated by ATP synthase for protein synthesis, processing, and export.
Regulatory network integration: Both energy metabolism and toxin production respond to environmental cues. Research demonstrates that three two-component systems (TCSs) - CLC_1093/CLC_1094, CLC_1914/CLC_1913, and CLC_0661/CLC_0663 - control toxin gene expression independently of botR/A, suggesting complex regulatory networks that might also influence metabolic genes like atpA .
Growth phase coordination: BoNT production occurs predominantly during the transition from exponential to stationary phase, a period when metabolic adjustments, potentially including ATP synthase regulation, are occurring .
Experimental approaches to investigate these connections would include comparative transcriptomic analysis of wild-type and toxin-deficient strains, metabolic flux analysis, and measuring ATP levels during toxin production phases.
ATP synthase likely plays a critical role in C. botulinum environmental adaptation through several mechanisms:
Energy homeostasis during environmental transitions: ATP synthase activity may be modulated as C. botulinum adapts to different nutrient availabilities and oxygen levels.
Response to pH changes: ATP synthase contributes to maintaining proton gradients, potentially helping C. botulinum adapt to environmental pH fluctuations.
Stress response: Under stress conditions, ATP synthase activity may be regulated to conserve energy while maintaining essential cellular functions.
This adaptation may be regulated by TCSs similar to those controlling toxin production. For instance, the TCS CLC_0661/CLC_0663, homologous to the PhoP/PhoR family typically involved in phosphate starvation response, might regulate energy metabolism genes including ATP synthase in response to nutrient limitation .
Recombinant C. botulinum atpA serves as a valuable molecular target for metabolism studies through several approaches:
Enzymatic characterization: Purified recombinant atpA, properly stored at -20°C or -80°C as recommended , can be reconstituted with other ATP synthase subunits to measure ATP synthesis/hydrolysis activities under various conditions.
Structure-function analysis: Site-directed mutagenesis of recombinant atpA can identify residues essential for function specifically in C. botulinum.
Protein-protein interaction studies: The recombinant protein can be used in pull-down assays to identify potential regulatory proteins that interact with ATP synthase.
Comparative studies: Comparing the properties of C. botulinum atpA with those from other bacterial species can reveal unique features of energy metabolism in this pathogen.
Development of specific inhibitors: The recombinant protein allows screening for compounds that specifically target C. botulinum ATP synthase without affecting host ATP synthases.
Several expression systems can be optimized for producing functional recombinant C. botulinum atpA:
| Expression System | Advantages | Optimization Parameters |
|---|---|---|
| E. coli BL21(DE3) | High expression levels, simple culturing | Lower temperature (16-20°C), reduced inducer concentration |
| E. coli Rosetta strains | Provides rare codons that may be present in C. botulinum genes | Codon optimization, growth medium supplementation |
| E. coli C41/C43(DE3) | Designed for membrane proteins, suitable if working with complete ATP synthase | Extended induction time, specialized media |
| Cell-free systems | Avoids toxicity issues, rapid production | Component optimization, energy regeneration systems |
| Bacillus subtilis | Gram-positive host more similar to C. botulinum | Promoter selection, secretion optimization |
The recombinant protein should be stored at -20°C or -80°C for extended storage as indicated in product information for commercial recombinant C. botulinum atpA .
Several complementary methodologies provide comprehensive assessment of ATP synthase activity:
ATP hydrolysis assays:
Coupled enzyme assays linking ATP hydrolysis to NADH oxidation
Malachite green assay to measure released phosphate
Luciferase-based assays to quantify remaining ATP
ATP synthesis assays:
Reconstitution in proteoliposomes with established proton gradients
Luciferin-luciferase detection of newly synthesized ATP
pH-sensitive fluorescent probes to monitor proton movement
Binding assays:
Isothermal titration calorimetry for nucleotide binding affinity
Fluorescence-based assays using fluorescent ATP analogs
Data should be analyzed using enzyme kinetics models to determine parameters like Km, Vmax, and inhibition constants, providing insights into catalytic efficiency and regulatory mechanisms.
Antisense RNA methodology can be adapted from toxin regulatory gene studies to investigate atpA function in C. botulinum:
Construction strategy:
Validation approaches:
Confirm reduced atpA expression using qRT-PCR
Measure ATP synthase activity in membrane fractions
Monitor growth kinetics and energy-dependent processes
Phenotypic analysis:
Assess impact on growth in different media and conditions
Measure ATP production capacity
Evaluate effects on toxin production and other energy-dependent processes
This approach would help determine the importance of atpA in C. botulinum metabolism and potentially reveal connections to toxin production systems .
Comprehensive analysis of ATP synthase kinetic data requires multiple analytical approaches:
Michaelis-Menten kinetics analysis:
Determine Km and Vmax using nonlinear regression
Generate Lineweaver-Burk, Eadie-Hofstee, or Hanes-Woolf plots for visualization
Compare kinetic parameters between wild-type and mutant proteins
Inhibition studies:
Calculate inhibition constants (Ki)
Classify inhibition mechanisms (competitive, non-competitive, etc.)
Determine IC50 values through dose-response curves
Environmental effects analysis:
Evaluate pH-dependent activity profiles
Determine temperature optima and stability
Assess effects of ions and small molecules on activity
The resulting parameters provide insights into catalytic mechanism, efficiency, and regulatory properties of C. botulinum ATP synthase.
Multiple bioinformatic approaches can be combined to comprehensively identify functional domains:
| Approach | Tools | Information Obtained |
|---|---|---|
| Multiple sequence alignment | MUSCLE, CLUSTAL Omega | Conserved regions across species, strain-specific variations |
| Motif analysis | PROSITE, PFAM | Functional motifs (e.g., Walker A/B motifs for ATP binding) |
| Structural prediction | AlphaFold, SWISS-MODEL | 3D structural models to visualize domains |
| Evolutionary conservation mapping | ConSurf | Identification of functionally important residues |
| Coevolution analysis | Direct Coupling Analysis | Residue pairs likely involved in structural/functional interactions |
| Domain prediction | InterProScan | Identification of known protein domains |
These approaches would help identify nucleotide-binding domains, catalytic sites, and interfaces with other subunits, guiding experimental studies of structure-function relationships.
Transcriptomic data analysis provides insights into atpA regulation within TCS networks:
Correlation analysis:
Differential expression analysis:
Compare atpA expression in TCS mutant strains versus wild-type
Identify conditions where atpA and TCS genes show coordinated expression changes
Network analysis:
Construct gene regulatory networks including atpA and TCS components
Identify potential master regulators affecting both energy metabolism and toxin production
Temporal analysis:
Track expression patterns throughout growth phases
Identify key transition points when regulation changes
Several approaches show promise for elucidating ATP synthase roles in pathogenicity:
Conditional knockdown systems: Developing inducible antisense or CRISPR interference systems to modulate atpA expression at specific growth stages.
Metabolic flux analysis: Tracing carbon and energy flow through central metabolism to ATP synthesis and toxin production pathways.
In vivo infection models: Studying atpA-modulated strains in appropriate models to assess effects on colonization and toxin production.
Structural biology approaches: Determining C. botulinum ATP synthase structure to identify unique features that might be targeted.
Multi-omics integration: Combining transcriptomics, proteomics, and metabolomics to develop comprehensive models of energy metabolism during toxin production.
These approaches would help clarify whether ATP synthase represents a potential therapeutic target to inhibit C. botulinum growth or toxin production.
The three TCS regulatory systems identified as controlling toxin production independently of botR/A (CLC_1093/CLC_1094, CLC_1914/CLC_1913, and CLC_0661/CLC_0663) may interact with energy metabolism through several mechanisms :
Direct regulation: TCS response regulators might directly bind to promoter regions of both toxin genes and metabolic genes including atpA.
Indirect regulation: TCS activation might trigger intermediate regulatory factors that coordinate both toxin production and energy metabolism.
Metabolic sensing: These TCSs might sense metabolic state or energy availability and adjust both ATP synthase expression and toxin production accordingly.
Growth phase coordination: The identified TCSs regulate toxin genes during the transition from exponential to stationary phase , a period when significant metabolic reprogramming occurs.
Experimental approaches to investigate these connections would include ChIP-seq to identify direct binding targets of response regulators, metabolomics to identify signals sensed by these TCSs, and systems biology modeling to map regulatory networks.